US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

North by Honeywell PAIN STOPPER EXTRA STRENGTH

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0074-2022
Class III · Low risk Terminated

AERO Tab PAIN RELIEVER

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0073-2022
Class III · Low risk Terminated

ZEE+ painaid ESF Extra-Strength Formula

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0072-2022
Class III · Low risk Terminated

Vica-Cet BACK PAIN RELIEF

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0071-2022
Class III · Low risk Terminated

PainAway II

Reason Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Ultra Seal Corporation D-0070-2022
Class III · Low risk Terminated

AllerClear D-24 hr

Reason Failed Moisture Limits

Sun Pharmaceutical Industries INC NDC 63981-724-15 D-0069-2022
Class III · Low risk Terminated

Cetirizine hydrochloride

Reason Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.

A-S Medication Solutions LLC. D-0096-2022
Class III · Low risk Ongoing

Butalbital

Reason Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0257-2022
Class III · Low risk Ongoing

Butalbital

Reason Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0256-2022
Class III · Low risk Terminated

Candesartan Cilexetil Tablets

Reason Failed Impurities/Degradation Specifications; out of specification for Related Compound

Viatris NDC 0378-3231-93 D-0798-2021
Class III · Low risk Terminated

Glycopyrrolate Injection

Reason Failed Impurities/Degradation Specifications

Meitheal Pharmaceuticals Inc NDC 71288-408-21 D-0801-2021
Class III · Low risk Terminated

Hydroquinone

Reason Subpotency: one product for active ingredient assay and another one for preservative assay

Monarch PCM, LLC NDC 69367-174-01 D-0818-2021
Class III · Low risk Terminated

Sodium Sulfacetamide

Reason Subpotency: one product for active ingredient assay and another one for preservative assay

Monarch PCM, LLC NDC 42808-103-06 D-0817-2021
Class III · Low risk Terminated

Donepezil HCL Tablets

Reason Subpotent

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-329-90 D-0784-2021
Class III · Low risk Terminated

Bleomycin for Injection

Reason Labeling: Not elsewhere classified: Mislabeling

Hikma Pharmaceuticals USA Inc. NDC 0143-9240-01 D-0771-2021
Class III · Low risk Terminated

Avicel

Reason Out of specification results for conductivity.

DuPont Nutrition USA, Inc D-0728-2021
Class III · Low risk Terminated

Lidocaine Ointment USP

Reason Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.

Teligent Pharma, Inc. NDC 52565-008-14 D-0785-2021
Class III · Low risk Terminated

Acetaminophen EXTRA STRENGTH Pain Reliever / Fever Reducer

Reason Labeling: Not Elsewhere Classified The primary label contains the words "enteric coated" but the tablet is not enteric coated and should only say 'coated tablet'

LNK International, Inc. NDC 46122-649-71 D-0665-2021
Class III · Low risk Terminated

Leukine

Reason FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.

Partner Therapeutics Inc NDC 71837-5843-5 D-0655-2021
Class III · Low risk Terminated

Erythromycin Topical Gel

Reason Failed Impurities/Degradation Specifications

Teligent Pharma, Inc. NDC 52565-033-30 D-0690-2021
Class III · Low risk Terminated

Erythromycin Topical Solution USP

Reason Failed Impurities/Degradation Specifications

Teligent Pharma, Inc. NDC 52565-027-59 D-0689-2021
Class III · Low risk Terminated

B-Force

Reason Superpotent

Grato Holdings, Inc. NDC 43857-0576-1 D-0653-2021